Cargando…
Scale-up of industrial microbial processes
Scaling up industrial microbial processes for commercial production is a high-stakes endeavor, requiring time and investment often exceeding that for laboratory microbe and process development. Omissions, oversights and errors can be costly, even fatal to the program. Approached properly, scale-up c...
Autores principales: | Crater, Jason S, Lievense, Jefferson C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995164/ https://www.ncbi.nlm.nih.gov/pubmed/29860483 http://dx.doi.org/10.1093/femsle/fny138 |
Ejemplares similares
-
Acquiring Pharmaceutical Industry Assets in the UK: 1 + 1 = 1?
por: Kanavos, Panos, et al.
Publicado: (2014) -
Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?
por: Atzor, Sabine, et al.
Publicado: (2013) -
Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities
por: Bauchau, Vincent, et al.
Publicado: (2023) -
Revision of Ireland’s Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs
por: O’Mahony, James F.
Publicado: (2021) -
Variations in institutional review board processes and consent requirements for trauma research: an EAST multicenter survey
por: Nahmias, Jeffry, et al.
Publicado: (2018)